Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms

Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin Combined With Half-dose Ticagrelor in Patients With Unruptured Intracranial Aneurysms With Normal CYP2C19 Metabolizer Phenotype

NCT06486363 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment

NCT00386191 ·Status: COMPLETED ·Phase: PHASE4

Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects

NCT00413608 ·Status: COMPLETED ·Phase: PHASE1

The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized and Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction

NCT02411903 ·Status: UNKNOWN ·Phase: PHASE4

The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)

NCT00385944 ·Status: COMPLETED ·Phase: PHASE2

Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events

NCT00979589 ·Status: COMPLETED ·Phase: PHASE3

Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)

NCT05566301 ·Status: RECRUITING

The Influence of CYP2C19 Polymorphism and Clinical Outcomes in Stroke Patients

NCT02711410 ·Status: COMPLETED

Clopidogrel Reloading in Clopidogrel Resistant Patients With ACS

NCT00444132 ·Status: COMPLETED ·Phase: PHASE3

Prasugrel Versus Clopidogrel in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)

NCT01090336 ·Status: UNKNOWN

The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease

NCT01260584 ·Status: COMPLETED ·Phase: PHASE4

Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm

NCT02675205 ·Status: COMPLETED ·Phase: PHASE3

Clopidogrel Monotherapy in Patients With High Bleeding Risk

NCT05223335 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of the Efficacy of Novel Biomarkers in Predicting Clopidogrel Resistance in Patients with Ischemic Stroke

NCT06753149 ·Status: NOT_YET_RECRUITING

Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)

NCT01463150 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Clopidogrel on Incidence of Silent Brain Infarction

NCT04698031 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

NCT00050817 ·Status: COMPLETED ·Phase: PHASE3

Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes

NCT01107899 ·Status: TERMINATED ·Phase: PHASE1

Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients

NCT01115738 ·Status: COMPLETED ·Phase: PHASE2

Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).

NCT01109784 ·Status: COMPLETED ·Phase: PHASE3

Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects

NCT00799045 ·Status: COMPLETED ·Phase: PHASE4

Clopidogrel/Aspirin Interaction Study

NCT01102439 ·Status: COMPLETED ·Phase: PHASE4

Antiplatelet Resistance Research in Patients With Peripheral Arterial Revascularization

NCT03953547 ·Status: COMPLETED

Platelet Inhibition and Transcranial Doppler (TCD)-Detected Microemboli During and After Carotid Artery Stenting (CAS) in Asymptomatic Patients Prior to Cardiac Surgery

NCT01146301 ·Status: COMPLETED ·Phase: PHASE4

Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy

NCT01495845 ·Status: COMPLETED ·Phase: PHASE1